News
Aquestive Therapeutics (AQST) has priced an underwritten offering of 21.25M shares at $4.00 each, expecting $85M in gross proceeds.
Vital Farms delivered a strong performance in Q2, with results that surpassed Wall Street expectations. Management pointed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback